MarketPeel
Insider Trading Intelligence
Pricing
…
CS

Curran Simpson

RGNX
CHIEF EXECUTIVE OFFICER · REGENXBIO INC. · CIK 0001346164
FILING MIX · LIFETIME48%/52%
BUYS
31
SELLS
34
TOTAL VALUE
$7.31M
COMPANIES
1
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
342,467
AVG SELL PX
$30.98
TRADE KIND
SHOWING 65 / 65
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
13 backtested trades · 8 horizons · 8 pending
Forward-return performance of every backtestable P/S trade by Curran Simpson, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d13+46.15%-1.60%-0.26%-1.34%+1.10%—
14d13+76.92%-4.96%-1.16%-3.81%-1.68%—
30d13+76.92%-10.88%-4.60%-6.28%-8.66%—
60d13+76.92%-17.30%-4.87%-12.43%-18.97%—
90d13+76.92%-12.08%-1.12%-10.95%-7.14%—
180d13+92.31%-27.00%+5.39%-32.39%-35.08%—
1y13(3 pending)+90.00%-23.94%+19.77%-43.70%-40.59%—
2y13(5 pending)+100.00%-48.61%+27.91%-76.52%-86.34%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
RGNX · 342,467 shares · as of Jan 6, 2026
0119,652239,303358,955478,606202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 31 buys / 34 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
RGNX
REGENXBIO INC.
PURCHASEGRANT
Stock grant
233,651——233,651Jan 6, 2026Jan 8, 2026 ↗View →
RGNX
REGENXBIO INC.
PURCHASEGRANT
Stock grant
144,864——342,467Jan 6, 2026Jan 8, 2026 ↗View →
RGNX
REGENXBIO INC.
SALE
Chief Executive Officer
18,559$14.40$267.2K197,603Jan 2, 2026Jan 6, 2026 ↗View →
RGNX
REGENXBIO INC.
SALE10b5-1
10b5-1 plan
20,811$12.62$262.6K216,162Oct 9, 2025Oct 10, 2025 ↗View →
RGNX
REGENXBIO INC.
SALE10b5-1
10b5-1 plan
7,624$10.03$76.5K236,973Sep 29, 2025Oct 1, 2025 ↗View →
RGNX
REGENXBIO INC.
SALE10b5-1
10b5-1 plan
7,734$10.02$77.5K244,597Sep 10, 2025Sep 12, 2025 ↗View →
RGNX
REGENXBIO INC.
SALE
Chief Executive Officer
4,701$8.23$38.7K252,331Jul 1, 2025Jul 3, 2025 ↗View →
RGNX
REGENXBIO INC.
PURCHASEGRANT
Stock grant
98,912——257,032Jan 2, 2025Jan 6, 2025 ↗View →
RGNX
REGENXBIO INC.
PURCHASEGRANT
Stock grant
476,606——476,606Jan 2, 2025Jan 6, 2025 ↗View →
RGNX
REGENXBIO INC.
SALE
Chief Executive Officer
11,917$7.73$92.1K158,120Jan 2, 2025Jan 6, 2025 ↗View →
RGNX
REGENXBIO INC.
PURCHASEGRANT
Stock grant
478,606——478,606Jan 2, 2025Jan 14, 2025 ↗View →
RGNX
REGENXBIO INC.
SALE10b5-1
10b5-1 plan
100$15.00$1.5K170,037Aug 1, 2024Aug 5, 2024 ↗View →
RGNX
REGENXBIO INC.
SALE10b5-1
10b5-1 plan
9,648$15.04$145.1K170,137Jul 29, 2024Jul 30, 2024 ↗View →
RGNX
REGENXBIO INC.
PURCHASEGRANT
Stock grant
272,189——272,189Jul 1, 2024Jul 3, 2024 ↗View →
RGNX
REGENXBIO INC.
PURCHASEGRANT
Stock grant
56,458——179,785Jul 1, 2024Jul 3, 2024 ↗View →
RGNX
REGENXBIO INC.
SALE
Chief Oper. & Tech. Officer
8,120$17.95$145.8K84,865Jan 2, 2024Jan 4, 2024 ↗View →
RGNX
REGENXBIO INC.
PURCHASEGRANT
Stock grant
61,050——61,050Jan 2, 2024Jan 4, 2024 ↗View →
RGNX
REGENXBIO INC.
PURCHASEGRANT
Stock grant
38,462——123,327Jan 2, 2024Jan 4, 2024 ↗View →
RGNX
REGENXBIO INC.
PURCHASEGRANT
Stock grant
67,945——92,985Jan 3, 2023Jan 5, 2023 ↗View →
RGNX
REGENXBIO INC.
SALE
Chief Oper. & Tech. Officer
2,076$22.68$47.1K25,040Jan 3, 2023Jan 5, 2023 ↗View →
RGNX
REGENXBIO INC.
PURCHASEGRANT
Stock grant
52,986——52,986Jan 3, 2023Jan 5, 2023 ↗View →
RGNX
REGENXBIO INC.
PURCHASEGRANT
Stock grant
10,700——27,116Jan 3, 2022Jan 4, 2022 ↗View →
RGNX
REGENXBIO INC.
PURCHASEGRANT
Stock grant
51,100——51,100Jan 3, 2022Jan 4, 2022 ↗View →
RGNX
REGENXBIO INC.
SALE
Chief Oper. & Tech. Officer
1,332$32.70$43.6K16,416Jan 1, 2022Jan 4, 2022 ↗View →
RGNX
REGENXBIO INC.
PURCHASE
Chief Oper. & Tech. Officer
1,240$19.50$24.2K18,988Jan 14, 2021Jan 14, 2021 ↗View →
RGNX
REGENXBIO INC.
SALE
Chief Oper. & Tech. Officer
1,240——0Jan 14, 2021Jan 14, 2021 ↗View →
RGNX
REGENXBIO INC.
PURCHASE
Chief Oper. & Tech. Officer
10,372$35.80$371.3K29,360Jan 14, 2021Jan 14, 2021 ↗View →
RGNX
REGENXBIO INC.
SALE
Chief Oper. & Tech. Officer
10,372——17,128Jan 14, 2021Jan 14, 2021 ↗View →
RGNX
REGENXBIO INC.
SALE
Chief Oper. & Tech. Officer
11,612$50.01$580.7K17,748Jan 14, 2021Jan 14, 2021 ↗View →
RGNX
REGENXBIO INC.
SALE
Chief Oper. & Tech. Officer
1,700$50.03$85.1K17,748Jan 12, 2021Jan 14, 2021 ↗View →
RGNX
REGENXBIO INC.
PURCHASE
Chief Oper. & Tech. Officer
1,700$19.50$33.1K19,448Jan 12, 2021Jan 14, 2021 ↗View →
RGNX
REGENXBIO INC.
SALE
Chief Oper. & Tech. Officer
1,700——1,240Jan 12, 2021Jan 14, 2021 ↗View →
RGNX
REGENXBIO INC.
SALE
Chief Oper. & Tech. Officer
5,185——2,940Jan 7, 2021Jan 11, 2021 ↗View →
RGNX
REGENXBIO INC.
SALE
Chief Oper. & Tech. Officer
5,185$50.01$259.3K17,748Jan 7, 2021Jan 11, 2021 ↗View →
RGNX
REGENXBIO INC.
PURCHASE
Chief Oper. & Tech. Officer
5,185$19.50$101.1K22,933Jan 7, 2021Jan 11, 2021 ↗View →
RGNX
REGENXBIO INC.
PURCHASEGRANT
Stock grant
62,300——62,300Jan 4, 2021Jan 6, 2021 ↗View →
RGNX
REGENXBIO INC.
PURCHASEGRANT
Stock grant
13,800——17,748Jan 4, 2021Jan 6, 2021 ↗View →
RGNX
REGENXBIO INC.
SALE
SVP, Product Development & CTO
3,692$51.37$189.7K3,948Feb 11, 2020Feb 12, 2020 ↗View →
RGNX
REGENXBIO INC.
SALE
SVP, Product Development & CTO
8,872$50.13$444.8K7,640Feb 11, 2020Feb 12, 2020 ↗View →
RGNX
REGENXBIO INC.
PURCHASE
SVP, Product Development & CTO
6,633$22.00$145.9K16,512Feb 11, 2020Feb 12, 2020 ↗View →
RGNX
REGENXBIO INC.
SALE
SVP, Product Development & CTO
6,633——0Feb 11, 2020Feb 12, 2020 ↗View →
RGNX
REGENXBIO INC.
PURCHASE
SVP, Product Development & CTO
4,253$19.50$82.9K26,901Feb 10, 2020Feb 12, 2020 ↗View →
RGNX
REGENXBIO INC.
SALE
SVP, Product Development & CTO
14,928——6,633Feb 10, 2020Feb 12, 2020 ↗View →
RGNX
REGENXBIO INC.
PURCHASE
SVP, Product Development & CTO
14,928$22.00$328.4K41,829Feb 10, 2020Feb 12, 2020 ↗View →
RGNX
REGENXBIO INC.
SALE
SVP, Product Development & CTO
4,253——8,125Feb 10, 2020Feb 12, 2020 ↗View →
RGNX
REGENXBIO INC.
PURCHASE
SVP, Product Development & CTO
12,479$35.80$446.7K54,308Feb 10, 2020Feb 12, 2020 ↗View →
RGNX
REGENXBIO INC.
SALE
SVP, Product Development & CTO
12,479——27,500Feb 10, 2020Feb 12, 2020 ↗View →
RGNX
REGENXBIO INC.
SALE
SVP, Product Development & CTO
44,429$50.22$2.23M9,879Feb 10, 2020Feb 12, 2020 ↗View →
RGNX
REGENXBIO INC.
PURCHASE
SVP, Product Development & CTO
471$35.80$16.9K28,285Feb 5, 2020Feb 7, 2020 ↗View →
RGNX
REGENXBIO INC.
SALE
SVP, Product Development & CTO
471——39,979Feb 5, 2020Feb 7, 2020 ↗View →
RGNX
REGENXBIO INC.
SALE
SVP, Product Development & CTO
5,637$50.00$281.9K22,648Feb 5, 2020Feb 7, 2020 ↗View →
RGNX
REGENXBIO INC.
SALE
SVP, Product Development & CTO
2,708——0Feb 5, 2020Feb 7, 2020 ↗View →
RGNX
REGENXBIO INC.
SALE
SVP, Product Development & CTO
1,000——12,378Feb 5, 2020Feb 7, 2020 ↗View →
RGNX
REGENXBIO INC.
PURCHASE
SVP, Product Development & CTO
1,000$19.50$19.5K26,856Feb 5, 2020Feb 7, 2020 ↗View →
RGNX
REGENXBIO INC.
SALE
SVP, Product Development & CTO
958——21,561Feb 5, 2020Feb 7, 2020 ↗View →
RGNX
REGENXBIO INC.
PURCHASE
SVP, Product Development & CTO
958$22.00$21.1K27,814Feb 5, 2020Feb 7, 2020 ↗View →
RGNX
REGENXBIO INC.
PURCHASE
SVP, Product Development & CTO
2,708$13.09$35.4K25,856Feb 5, 2020Feb 7, 2020 ↗View →
RGNX
REGENXBIO INC.
SALE
SVP, Product Development & CTO
5,922$50.00$296.1K23,148Jan 17, 2020Jan 21, 2020 ↗View →
RGNX
REGENXBIO INC.
SALE
SVP, Product Development & CTO
1,622——13,378Jan 17, 2020Jan 21, 2020 ↗View →
RGNX
REGENXBIO INC.
PURCHASE
SVP, Product Development & CTO
800$35.80$28.6K29,070Jan 17, 2020Jan 21, 2020 ↗View →
RGNX
REGENXBIO INC.
PURCHASE
SVP, Product Development & CTO
2,700$22.00$59.4K28,270Jan 17, 2020Jan 21, 2020 ↗View →
RGNX
REGENXBIO INC.
PURCHASE
SVP, Product Development & CTO
1,622$19.50$31.6K25,570Jan 17, 2020Jan 21, 2020 ↗View →
RGNX
REGENXBIO INC.
SALE
SVP, Product Development & CTO
2,700——22,519Jan 17, 2020Jan 21, 2020 ↗View →
RGNX
REGENXBIO INC.
SALE
SVP, Product Development & CTO
800——40,450Jan 17, 2020Jan 21, 2020 ↗View →
RGNX
REGENXBIO INC.
PURCHASEGRANT
Stock grant
46,000——46,000Jan 2, 2020Jan 6, 2020 ↗View →
Other insiders · RGNX
Loading peer insiders…
About this filer
CIK 0001346164
ROLE
Chief Executive Officer
PRIMARY
RGNX
COMPANIES
1
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001346164DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback